NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InSilicoTrials Technologies

InSilicoTrials Technologies

Private
TriesteHealthcare & Life Scienceshttps://insilicotrials.com/

Last Round

Grant

Jan 28, 2021

Total Funding Raised

$5.71M

Company Overview

InSilicoTrials Technologies is a health tech company that provides a cloud-based platform with AI and simulation to predict drug and medical device safety and efficacy for pharmaceutical and biotech organizations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Medical Devices, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

in silico trialscomputational simulationsimulation platformAI drug discoveryvirtual clinical trialsmodeling and simulationsynthetic control armdigital twinvirtual patientdrug developmentmedical device simulationcomputational evidencecardiac safety assessmentM&SADME prediction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InSilicoTrials Technologies Comparables

Compare InSilicoTrials Technologies with similar companies based on industry and business-model similarity.

InSilicoTrials Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantHealth
86%
Nova In Silico
83%
Unlearn
79%

InSilicoTrials Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 28, 2021
Series AJul 27, 2020

Key People

Founding team and executive leadership

Luca Emili

CEO

Executive Team

Luca Mili

CEO

Executive Team

Alessandro Collesano

Fractional CFO

Executive Team

Mario Torchia

Chief Operating Officer

Executive Team

InSilicoTrials Technologies Investors

Notable investors and investment history

InSilicoTrials Technologies investors
InvestorRounds
European Union's Horizon Research and Innovation programGrant
Pi CampusSeries A
United VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 54% MoM, reaching 5.4K.

  • Apr 6, 2025

    Monthly visitors increased 125% MoM.

InSilicoTrials Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InSilicoTrials Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InSilicoTrials Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersTrieste
Employee Range29
Year Founded2017
Last FundingJan 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.